[EN] NOVEL COMPOUNDS AS WIP1 INHIBITORS<br/>[FR] NOUVEAUX COMPOSÉS EN TANT QU'INHIBITEURS DE WIP1
申请人:GLAXOSMITHKLINE LLC
公开号:WO2012149102A1
公开(公告)日:2012-11-01
This invention relates to the use of acylated alanine derivatives for the modulation, notably the inhibition of the activity of WIP1. Suitably, the present invention relates to the use of acylated alanine derivatives in the treatment of cancer.
本发明涉及酰化丙氨酸衍生物用于调节WIP1活性,特别是抑制其活性。适当地,本发明涉及酰化丙氨酸衍生物在癌症治疗中的应用。